Orthopedic News and Research

RSS

Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.

Physiotherapy Associates opens new clinic in Silver Spring

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces the opening of a new physical therapy clinic in Silver Spring, MD.

4 Feb 2011

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.

2 Feb 2011

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

BioMimetic Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled an Orthopedic and Rehabilitation Devices Panel meeting on May 12, 2011 to review the Company's Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S.

1 Feb 2011

OREF, Biomet donate $1.3 million for medical education programs in orthopaedic surgery

Biomet, and the Orthopaedic Research and Education Foundation announced today Biomet's 2011 donation of $1.3 million for funding graduate medical education programs in orthopaedic surgery.

29 Jan 2011

Physiotherapy Associates opens physical therapy clinic in Castle Rock, CO

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces a new clinic location in Castle Rock, CO. The clinic offers a comprehensive range of physical therapy services, including: orthopedics; back and neck programs; hand therapy; vestibular rehabilitation; workers' compensation; orthopedic pediatrics; and foot and ankle programs.

29 Jan 2011

BioTime announces acquisition of CTI assets

BioTime, today announced that it has acquired substantially all the assets of Cell Targeting, a Cleveland, Ohio-based biotechnology company conducting research in regenerative medicine.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

Physicians' second opinions influenced by the first opinion

A new study by Ben-Gurion University of the Negev (BGU) researchers indicates that physicians who give second opinions may be influenced by the first opinion and other external factors.

28 Jan 2011

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating post-operative pain in hospitalized patients. A Phase III study published in the peer-reviewed journal Pain Practice concluded that IV ibuprofen significantly reduced both morphine use and self-reported pain intensity in patients recovering from abdominal hysterectomy compared to morphine alone.

27 Jan 2011

ACS NSQIP Pediatric helps hospitals prevent complications

A first of its kind surgical quality improvement program for children has the potential to identify outcomes of children's surgical care that can be targeted for quality improvement efforts to prevent complications and save lives. The results of a study of the American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP Peds) phase 1 pilot were published in the January issue of the Journal of the American College of Surgeons.

27 Jan 2011

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced it has been granted Food and Drug Administration conditional Investigational Device Exemption approval to evaluate the safety and effectiveness of its CorPath® 200 System in delivering and manipulating coronary guidewires and stent/balloon systems in percutaneous coronary interventions procedures.

27 Jan 2011

New Center for Precision Joint Replacement opens at Salt Lake Regional Medical Center

Salt Lake Regional Medical Center today announced the grand opening of the hospital's Center for Precision Joint Replacement, which specializes in the practice of complex knee, hip and shoulder joint replacements in Utah.

27 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Cardo and Arthrex enter Asset Purchase Agreement

Cardo Medical, Inc., an orthopedic medical device company based in Los Angeles, California, its wholly-owned subsidiary, Cardo Medical, LLC, and Arthrex, Inc., a leading provider of sports medicine product development and educational services for orthopedic surgeons based in Naples, Florida, announced today that they signed an asset purchase agreement.

25 Jan 2011

FDA grants pre-market clearance for SBi's rHead Extended Stem

Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.

From Evident Corporation - Life Sciences 24 Jan 2011

FDA approves On-X AAP with Vascutek Gelweave Valsalva Graft

On-X Life Technologies, announced today that it has received approval from the U.S. Food and Drug Administration to market the On-X Ascending Aortic Prosthesis with the Vascutek Gelweave Valsalva Graft.

23 Jan 2011

$Medicare reimbursed for only a fraction of the services recommended by government task force, study finds$

Medicare reimbursed for only a fraction of the services recommended by government task force, study finds

Health care reform should be able to mend a disconnect that has existed between the recommendations of the U.S. Preventive Services Task Force (USPSTF), a task force charged by the government to review clinical preventive health services for older adults, and Medicare coverage for those services, a new UCLA-led study finds.

21 Jan 2011

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

21 Jan 2011

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.

20 Jan 2011

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

U.S. Physical Therapy, a national operator of outpatient physical therapy clinics, announced that it has successfully launched a workers compensation and disability initiative called Fit2WRK. Fit2WRK provides an integrated solution for the management and prevention of injuries in the workplace.

20 Jan 2011

Orthopedic News and Research

Physiotherapy Associates opens new clinic in Silver Spring

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

FDA schedules panel meeting date for BioMimetic Therapeutics's Augment Bone Graft PMA

OREF, Biomet donate $1.3 million for medical education programs in orthopaedic surgery

Physiotherapy Associates opens physical therapy clinic in Castle Rock, CO

BioTime announces acquisition of CTI assets

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Physicians' second opinions influenced by the first opinion

Phase III study affirms safety and efficacy of Cumberland's Caldolor for post-operative pain

ACS NSQIP Pediatric helps hospitals prevent complications

FDA approves Corindus CorPath 200 System for pivotal trial to evaluate safety, effectiveness

New Center for Precision Joint Replacement opens at Salt Lake Regional Medical Center

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Cardo and Arthrex enter Asset Purchase Agreement

FDA grants pre-market clearance for SBi's rHead Extended Stem

FDA approves On-X AAP with Vascutek Gelweave Valsalva Graft

Medicare reimbursed for only a fraction of the services recommended by government task force, study finds

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

U.S. Physical Therapy launches Fit2WRK to provide solutions for prevention of injuries in workplace

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News